Search Results 241-250 of 16792 for Flutamide

  1. Gemtuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Gemtuzumab injection is used alone or together with other medicines (eg, cytarabine, daunorubicin) to treat newly-diagnosed CD33-positive acute myeloid leukemia ...

  2. Lamivudine and tenofovir (oral route) - Side effects & dosage - Mayo Clinic

    Lamivudine and tenofovir combination is used together with other antiviral medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus ...

  3. Margetuximab-cmkb (intravenous route) - Side effects & uses - Mayo Clinic

    Margetuximab-cmkb injection is used to treat metastatic (cancer that has spread) HER2-positive breast cancer in patients who have received two or more anti-HER2 ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  5. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of REGN3500 monotherapy compared with placebo treatment in adult patients with moderate-to- ...

  6. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  7. Hematology - Clinical trials

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  8. Hematology - Clinical trials

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  9. Clinical trials - Oncology (Medical)

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

  10. Friedreich's Ataxia Clinical Trials - Mayo Clinic Research

    The primary purpose of this dose-ranging study is to assess the safety and tolerability of 3 ascending doses of LX2006 gene therapy for the purpose of selecting ...